Easom Eric Insider Trading Activity

Average Profitability
61.1%
Insider Buys Quantity
2
Insider Buys Sum
$103,740.00
Insider Sells Quantity
17
Insider Sells Sum
$1.55M

Insider Activity of Easom Eric

According to the SEC Form 4 filings, Easom Eric, being in a position of

  1. Chief Executive Officer at AN2 Therapeutics, Inc.,
    оver the last 12 months, has bought 50000 shares for $49,970, and sold 0 shares,
    over all time since 2022-10-20, has bought 60000 shares for $103,740, and sold 97008 shares for $1.55M.

The largest purchase of all time was on 2023-05-15 and amounted to 10000 shares of AN2 Therapeutics, Inc. for $53,770.

The largest sale of all time was on 2022-10-21 and amounted to 13951 share of AN2 Therapeutics, Inc. for $228,240.

Biography of Easom Eric

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $49,9701100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2024-11-18PurchaseAN2 Therapeutics, Inc.
ANTX
Chief Executive Officer
50,000
0.1001%
$1.00$49,970+32.5%
2024-01-02SaleAN2 Therapeutics, Inc.
ANTX
Chief Executive Officer
2,777
0.1118%
$20.09$55,802-89.23%
2023-05-15PurchaseAN2 Therapeutics, Inc.
ANTX
Chief Executive Officer
10,000
0.1078%
$5.38$53,770+61.1%
2022-11-14SaleAN2 Therapeutics, Inc.
ANTX
Chief Executive Officer
23
0.0007%
$15.04$346-34.44%
2022-11-10SaleAN2 Therapeutics, Inc.
ANTX
Chief Executive Officer
4,413
0.1355%
$15.32$67,628-34.35%
2022-11-09SaleAN2 Therapeutics, Inc.
ANTX
Chief Executive Officer
10,111
0.3163%
$15.61$157,847-39.23%
2022-11-08SaleAN2 Therapeutics, Inc.
ANTX
Chief Executive Officer
7,055
0.2203%
$15.58$109,947-36.64%
2022-11-07SaleAN2 Therapeutics, Inc.
ANTX
Chief Executive Officer
12,203
0.3923%
$16.04$195,741-43.07%
2022-11-04SaleAN2 Therapeutics, Inc.
ANTX
Chief Executive Officer
8,828
0.2795%
$15.80$139,474-39.61%
2022-11-03SaleAN2 Therapeutics, Inc.
ANTX
Chief Executive Officer
14,165
0.447%
$15.75$223,058-39.46%
2022-11-02SaleAN2 Therapeutics, Inc.
ANTX
Chief Executive Officer
1,544
0.0466%
$15.07$23,263-35.58%
2022-10-31SaleAN2 Therapeutics, Inc.
ANTX
Chief Executive Officer
2,688
0.0829%
$15.39$41,363-33.08%
2022-10-28SaleAN2 Therapeutics, Inc.
ANTX
Chief Executive Officer
1,683
0.0509%
$15.09$25,392-35.96%
2022-10-27SaleAN2 Therapeutics, Inc.
ANTX
Chief Executive Officer
924
0.0284%
$15.36$14,190-37.38%
2022-10-26SaleAN2 Therapeutics, Inc.
ANTX
Chief Executive Officer
1,678
0.0508%
$15.10$25,342-35.41%
2022-10-25SaleAN2 Therapeutics, Inc.
ANTX
Chief Executive Officer
4,806
0.1517%
$15.75$75,672-38.57%
2022-10-24SaleAN2 Therapeutics, Inc.
ANTX
Chief Executive Officer
2,866
0.0929%
$16.17$46,344-40.91%
2022-10-21SaleAN2 Therapeutics, Inc.
ANTX
Chief Executive Officer
13,951
0.4574%
$16.36$228,240-41.22%
2022-10-20SaleAN2 Therapeutics, Inc.
ANTX
Chief Executive Officer
7,293
0.2438%
$16.68$121,672-41.94%
Total: 19
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.